| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | EVP & Chief Financial Officer
2 companies
James M Head is EVP & Chief Financial Officer at CTEV, with reported holdings spanning 2 companies. James M Head's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $78.6M at current prices.
James M Head's largest disclosed position is in CTEV as EVP & Chief Financial Officer, worth about $77.3M. Net of sales, the CTEV filings show accumulation of 300,000 shares.
James M Head has 14 Form 4 filings on record from January 2021 to April 2026, across 3 companies: Chief Financial Officer at Alignment Healthcare (ALHC), 2025–2026; Director at Sally Beauty (SBH), 2021–2026; EVP & Chief Financial Officer at Claritev (CTEV), 2021–2024.
The 17 reported transactions were 10 option or other derivative awards, 4 stock awards, 1 open-market sale and 1 tax withholding, plus smaller numbers of other types.
Counted by filing, the open-market trades come to 1 purchase worth about $1.3M and 1 sale worth about $234K.
The only open-market purchase was 300,000 shares of CTEV at an average $4.34 on November 29, 2021, about $1.3M. Twelve months later CTEV was down 65%.
The only open-market sale was 11,100 shares of ALHC at an average $21.08 on April 7, 2026, about $234K.